# A Study of T2000 in Essential Tremor

> **NCT00321087** · PHASE2 · TERMINATED · sponsor: **Sun Pharmaceutical Industries, Inc.** · enrollment: 10 (actual)

## Conditions studied

- Essential Tremor

## Interventions

- **DRUG:** T2000
- **DRUG:** T2000
- **DRUG:** T2000

## Key facts

- **NCT ID:** NCT00321087
- **Lead sponsor:** Sun Pharmaceutical Industries, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-08
- **Primary completion:** 2007-07
- **Final completion:** 2007-12
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2014-01-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00321087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00321087, "A Study of T2000 in Essential Tremor". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00321087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*